{
    "eid": "2-s2.0-85117337744",
    "title": "Effects of early estradiol valerate administration on bone turnover markers in surgically induced menopausal women",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Reproductive Medicine",
            "@code": "2743",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Obstetrics and Gynecology",
            "@code": "2729",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Bone turnover markers",
        "Estradiol valerate",
        "Serum CTX",
        "Serum P1NP",
        "Surgical menopause"
    ],
    "authors": [
        "Jarika Vatrasresth",
        "Ammarin Suwan",
        "Krasean Panyakhamlerd"
    ],
    "citedby-count": 1,
    "ref-count": 39,
    "ref-list": [
        "Risk of mortality following clinical fractures",
        "The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations",
        "The aging skeleton",
        "A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men",
        "The menopausal age and climacteric complaints in Thai women in Bangkok",
        "Effects of oophorectomy and hormone replacement therapy on pituitary-gonadal function",
        "Surgical menopause",
        "Prophylactic oophorectomy in premenopausal women and long-term health",
        "Long-term health consequences of premature or early menopause and considerations for management",
        "Elective oophorectomy in the United States: trends and in-hospital complications, 1998\u20132006",
        "Biochemical markers of bone turnover\u2014uses and limitations",
        "Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards",
        "Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women",
        "Comparison of the acute alterations in serum bone turnover markers and bone mineral density among women with surgical menopause",
        "Bone loss rate in the lumbar spine: a comparison between natural and surgically induced menopause",
        "hormone therapy position statement of The North American Menopause Society",
        "Hormone replacement therapy and the risk of endometrial cancer: a systematic review",
        "Hormone therapy in postmenopausal women and risk of endometrial hyperplasia",
        "Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence",
        "Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials",
        "A practitioner's toolkit for managing the menopause",
        "Premature ovarian insufficiency: an International Menopause Society White Paper",
        "Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy",
        "A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women",
        "Use of bone turnover markers in postmenopausal osteoporosis",
        "Bone turnover markers: use in osteoporosis",
        "Effect of feeding on bone turnover markers and its impact on biological variability of measurements",
        "Bone turnover: biology and assessment tools",
        "The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women",
        "The mechanisms of estrogen regulation of bone resorption",
        "Markers of bone turnover in postmenopausal women receiving hormone replacement therapy",
        "Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women",
        "The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation",
        "Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women\u2019s health initiative randomized trial",
        "Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update",
        "Changes in bone mineral density and bone turnover in patients on 'drug holiday' following bisphosphonate therapy: real-life clinic setting",
        "2016 IMS Recommendations on women's midlife health and menopause hormone therapy",
        "American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update",
        "ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Gender Health Clinic",
        "King Chulalongkorn Memorial Hospital",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}